This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Civitas Solutions (CIVI) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Civitas Solutions (CIVI) delivered earnings and revenue surprises of 107.14% and 1.57%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
CIVI or HQY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CIVI vs. HQY: Which Stock Is the Better Value Option?
New Strong Buy Stocks for July 3rd
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
Should Value Investors Pick Civitas (CIVI) Stock?
by Zacks Equity Research
Civitas (CIVI) is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front.
Why Civitas Solutions (CIVI) Could Be Positioned for a Slump
by Zacks Equity Research
It seems to be a wise decision for investors to drop Civitas Solutions (CIVI) stock considering its negative estimate revision, price depreciation as well as unfavorable Zacks rank.
Civitas Solutions (CIVI) to Acquire Habilitative Services
by Zacks Equity Research
Civitas Solutions' (CIVI) proposed acquisition of Habilitative Services will aid the company in capturing the lucrative Minnesota market.
Civitas Solutions (CIVI) Q3 Earnings Beat, Revenues Miss
by Zacks Equity Research
Civitas Solutions (CIVI) gains on strength in Post-Acute Specialty Rehabilitation Services and Adult Day Health services in Q3. However, tweaked full-year 2017 guidance signals dull prospects.
Civitas Solutions (CIVI) Acquires Country Life Care Center
by Zacks Equity Research
Civitas Solutions, Inc. (CIVI) recently announced the acquisition of Country Life Care Center, a rehabilitation and post-acute care facility located in Riverton, UT.
Civitas Solutions (CIVI) Extends ADH Platform to New Jersey
by Zacks Equity Research
Civitas Solutions, Inc. (CIVI) recently announced that it has expanded its platform of Adult Day Health services to the state of New Jersey.
Weakness Seen in Civitas Solutions (CIVI) Estimates: Should You Stay Away?
by Zacks Equity Research
Civitas Solutions, Inc. (CIVI), which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year.